Foot and mouth disease: A revised policy is required [1]

Journal of Clinical Microbiology

Volumn 39, Issue 10, 2001, Pages 3808-

  Bayry, J ^a   Kaveri, S V ^a  

^a HÔPITAL BROUSSAIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADJUVANT; FOOT AND MOUTH DISEASE VACCINE; INACTIVATED VACCINE;

EPIDEMIC; FOOT AND MOUTH DISEASE; HEALTH CARE POLICY; INFECTION CONTROL; INFECTION PREVENTION; LETTER; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; VACCINATION;

ANIMALS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; PUBLIC POLICY; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 0034788150     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.39.10.3808.2001     Document Type: Letter

References (8)

1. International bank for foot-and-mouth disease vaccine: Assessment of Montanide ISA 25 and ISA 206, two commercially available oil adjuvants
2. Emergency vaccination of sheep against foot-and-mouth disease: Protection against disease and reduction in contact transmission
3. The foot-and-mouth epidemic in Great Britain: Pattern of spread and impact of interventions
4. A recent history of foot-and-mouth disease
5. Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA
6. Protection of cattle and swine against foot-and-mouth disease using biosynthetic peptide vaccines
7. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine
8. Foot-and-mouth disease under control in the UK